Dynamic phosphorylation of cGAS by DNA-PKcs and PPP1CC balances DNA repair and innate immunity.

Authors

Jin Jia, Shuting Lai, Shanshan Gao, Hejiang Guo, Saiyu Li, Hua Guan, Zhenyang Yu, Ping-Kun Zhou

Published in

Medical oncology (Northwood, London, England). Volume 43. Issue 10. Sep 10, 2026. Epub Sep 10, 2026.

Abstract

Cyclic GMP-AMP synthase (cGAS) is a DNA sensor that localizes to both the cytosol and the nucleus, with dynamic nucleocytoplasmic shuttling. In the cytosol, it drives innate immune signaling upon detecting misplaced self-DNA or foreign DNA. In the nucleus, cGAS is normally tethered to chromatin and catalytically silent, but upon genotoxic stress it is reactivated and engages in DNA damage repair.How cGAS temporally coordinates these dual functions during genotoxic stress remains unresolved. In this study, we identified a context-dependent phosphorylation timer in cells with detectable nuclear cGAS that balances cGAS effects on immune signaling and DNA repair. In G1 phase, cGAS is rapidly phosphorylated by DNA-PKcs after irradiation. This modification suppresses cGAS catalytic activity and delays downstream immune signaling without affecting non-homologous end joining (NHEJ) repair, thereby prioritizing DNA repair over immune activation. Subsequent dephosphorylation by PPP1CC, occurring 8-12 h later, releases cGAS from damage sites and reactivates the cGAS-STING pathway.In S phase, phosphorylated cGAS selectively blocks homologous recombination(HR) while preserving NHEJ. This prevents pathway competition and favors rapid and efficient repair.Later, PPP1CC-mediated dephosphorylation inhibits NHEJ, restores HR competence, and reactivates cGAS catalytic activity. These findings reveal a spatiotemporal mechanism that couples DNA repair progression to immune activation, suggesting that the phosphorylation status of cGAS may inform the therapeutic timing of combined radiotherapy and immunotherapy.

PMID:
42720700
Bibliographic data and abstract were imported from PubMed on 10 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.